It’s been a tough few years for the beloved “value investor.” Never one to be lured into the small cap bubbles and eye watering share price movements we saw during the Covid biotech boom or more recently in 2025 with certain AI and bitcoin treasury companies commanding 100x revenue multiple or hefty *premiums* to NAV. Amongst all the hysteria, value investors remained unwaveringly loyal to their investment criteria – underpinned by fundamentals of revenues, cash, traditional business models an ....
